Financial statements Starpharma
Cash flow statement of Starpharma
Company age:
Age:
17 y. 8 m. 6 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of STARPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | - | -547 184,52 | 2 601 966,81 | 2 973 572,79 | -2 532 528,22 | 14 079 388,00 |
| Net cash flow from investing activities | - | 49 538,72 | -8 097 834,77 | -4 347 846,10 | -35 952 423,67 | -5 763 673,15 |
| Net cash flow from financial activities | - | -172 530,20 | 8 800 584,30 | -1 594 874,41 | 39 732 375,19 | -6 839 118,21 |
| Total net cash flow | - | -670 176,00 | 3 304 716,34 | -2 969 147,72 | 1 247 423,30 | 1 476 596,64 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.